The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness
This randomized controlled trial investigated the effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone (DHT) levels in men with male pattern baldness. Over 28 days, participants taking 5 mg/day of finasteride experienced a significant reduction in scalp DHT levels (from 6.40 to 3.62 pmol/g) and
June 26, 2025
No Comments